TargetMol

Acridine, 1-azido-

Product Code:
 
TAR-T29621
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29621-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29621-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Acridine, 1-azido- is a bioactive chemical.
CAS:
78276-11-6
Molecular Weight:
220.23
Purity:
0.98
SMILES:
[N-]=[N+]=NC1=CC=CC2=NC=3C=CC=CC3C=C12

References

Yu F, Zhang Y, Ye L, Tang Y, Ding G, Zhang X, Yang Z. A novel anti proliferative pentapeptide (ILYMP) isolated from Cyclina sinensis protein hydrolysate induces apoptosis of DU 145 prostate cancer cells. Mol Med Rep. 2018 May 14. doi: 10.3892/mmr.2018.9019. [Epub ahead of print] PubMed PMID: 29767237. Mohammadi P, Hassani Bafrani H, Tavalaee M, Dattilo M, Nasr-Esfahani MH. One-carbon cycle support rescues sperm damages in experimentally induced varicocele in rats. BJU Int. 2018 May 11. doi: 10.1111/bju.14385. [Epub ahead of print] PubMed PMID: 29752770. Kamalidehghan B, Ghafouri-Fard S, Motevaseli E, Ahmadipour F. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng. Drug Des Devel Ther. 2018 May 4;12:1119-1133. doi: 10.2147/DDDT.S156826. eCollection 2018. PubMed PMID: 29765202; PubMed Central PMCID: PMC5942175. Vakili Zahir N, Nakhjavani M, Hajian P, Shirazi FH, Mirzaei H. Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines. Iran J Pharm Res. 2018 Winter;17(1):261-267. PubMed PMID: 29755557; PubMed Central PMCID: PMC5937096.